Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Ibere Pharmaceuticals (IBERU) since 2021 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Ibere Pharmaceuticals. Table 2 shows the detailed insider transactions. This company's CIK number is 1835205.
Total stock buying since 2021: $100,000.
Total stock sales since 2021: $0.
Total stock option exercises since 2021: $0.
Insider Buying | Insider Sales | Option Exercises | ||||
---|---|---|---|---|---|---|
Year | Shares | Value | Shares | Value | Shares | Value |
2021 | 10,000 | $100,000 | 0 | $0 | 0 | $0 |
Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
---|---|---|---|---|---|---|
year-month | Shares | Value | Shares | Value | Shares | Value |
2021-03 | 10,000 | $100,000 | 0 | $0 | 0 | $0 |
Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
---|---|---|---|---|---|
2021-03-02 | Vollmer Louis J. | Buy | 10,000 | 10.00 | 100,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of IBERU listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Ibere Pharmaceuticals (symbol IBERU, CIK number 1835205) see the Securities and Exchange Commission (SEC) website.